SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma
Condition(s):Advanced Dedifferentiated LiposarcomaLast Updated:January 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Dedifferentiated LiposarcomaLast Updated:January 12, 2023Recruiting
Condition(s):Dedifferentiated LiposarcomaLast Updated:April 14, 2015Withdrawn
Condition(s):Advanced Dedifferentiated Liposarcoma; Locally Advanced Dedifferentiated Liposarcoma; Metastatic Dedifferentiated Liposarcoma; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Unresectable Dedifferentiated LiposarcomaLast Updated:February 20, 2024Recruiting
Condition(s):Leiomyosarcoma; LiposarcomaLast Updated:December 6, 2023Terminated
Condition(s):Soft Tissue SarcomaLast Updated:January 23, 2024Active, not recruiting
Condition(s):Dedifferentiated Liposarcoma; Soft Tissue Sarcoma; Sarcoma,Soft Tissue; Sarcoma; Recurrent Dedifferentiated Liposarcoma; Unresectable Dedifferentiated Liposarcoma; Metastatic Dedifferentiated LiposarcomaLast Updated:January 10, 2024Recruiting
Condition(s):Liposarcoma, DedifferentiatedLast Updated:February 14, 2024Active, not recruiting
Condition(s):Dedifferentiated LiposarcomaLast Updated:September 14, 2021Completed
Condition(s):Liposarcoma, DedifferentiatedLast Updated:March 26, 2024Recruiting
Condition(s):Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaLast Updated:January 25, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.